|
Aug 12
|
SELLAS Life Sciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
|
|
Aug 7
|
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification
|
|
Jul 31
|
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
|
|
Jun 5
|
SELLAS Life Sciences Expands Scientific Advisory Board with Addition of Two World-Renowned Hematology and Oncology Experts
|
|
May 20
|
SELLAS Life Sciences to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase
|
|
May 13
|
SELLAS Life Sciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
|
|
Jan 2
|
SELLAS to Host Corporate Update Call on January 8, 2025, at 9:00 am ET
|